Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Impact of Self-Reported Pre-Transplant Quality of Life (QOL) on Long-Term Survival after Allogeneic or Autologous Hematopoietic Cell Transplantation (HCT)

F. Lennie Wong, PhD, Jennifer Berano-Teh, Liton F. Francisco, BS, Aida Siyahian, Liezl Atencio, Alicia Gonzales, Saro Armenian, DO, MPH, Stephen J. Forman, MD, Smita Bhatia, MD MPH

Blood (2016) 128 (22): 3598.

https://doi.org/10.1182/blood.V128.22.3598.3598

Published: 2016

Journal Articles

Incidence and Predictors of Late-Occurring Central Nervous System Complications in Allogeneic Hematopoietic Cell Transplant Survivors

Aida Siyahian, Heeyoung Kim, MS, Jennifer Berano Teh, Howard Chang, Liezl Atencio, Alicia Gonzales, F. Lennie Wong, PhD, Ryotaro Nakamura, MD, Canlan Sun, PhD, Saro Armenian, DO, MPH

Blood (2016) 128 (22): 5799.

https://doi.org/10.1182/blood.V128.22.5799.5799

Published: 2016

Journal Articles

Progressive Decline in Late Mortality after Hematopoietic Cell Transplantation (HCT) over 40 Years - a Report from BMTSS

Liton F. Francisco, BS, Saro Armenian, DO, MPH, Mukta Arora, MD, Yanjun Chen, MS, Jessica Wu, BA, James A. Watson, MD, Lindsey Hageman, MPH, Emily C. Ness, BA, Mariel Parman, MPH, Kevin D. Battles, BS, Can-Lan Sun, PhD, Ravi Bhatia, MD, Daniel J. Weisdorf, MD, Stephen J. Forman, MD, Smita Bhatia, MD MPH

Blood (2016) 128 (22): 691.

https://doi.org/10.1182/blood.V128.22.691.691

Published: 2016

Journal Articles

Long-Term Morbidity and Mortality Experienced By Chronic Myeloid Leukemia (CML) Patients after Allogeneic Hematopoietic Cell Transplantation (HCT) - a Report from BMTSS-2

Jessica Wu, BA, Yanjun Chen, MS, Lindsey Hageman, MPH, Can-Lan Sun, PhD, Liton F. Francisco, BS, Emily C. Ness, BA, Mariel Parman, MPH, James A. Watson, MD, Daniel J. Weisdorf, MD, David S. Snyder, MD, Philip McGlave, MD, Stephen J. Forman, MD, Mukta Arora, MD, Saro Armenian, DO, MPH, Ravi Bhatia, MD, Smita Bhatia, MD MPH

Blood (2016) 128 (22): 823.

https://doi.org/10.1182/blood.V128.22.823.823

Published: 2016

Journal Articles

Long-Term Follow up of Patients with HIV-Associated Non-Hodgkin Lymphoma (NHL) after Autologous Stem Cell Transplantation (ASCT)

Liana Nikolaenko, MD, Saro Armenian, DO, MPH, Joseph C. Alvarnas, MD, John A. Zaia, MD, Leanne Goldstein, DrPH, Maria Viviana Marroquin, Amrita Y. Krishnan, MD

Blood (2016) 128 (22): 4614.

https://doi.org/10.1182/blood.V128.22.4614.4614

Published: 2016

Journal Articles

Physiologic Frailty Among Hematopoietic Cell Transplantation (HCT) Survivors Suggests Accelerated Aging and Is a Predictor for Premature Mortality: A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

Mukta Arora, MD MS, Can-Lan Sun, PhD, Kirsten K. Ness, PhD, Jennifer Berano Teh, MD, Jessica Wu, Liton F. Francisco, BS, Saro Armenian, DO, MPH, Amy Schad, MPH, CCRP, Golnaz Namdar, MPH, Alysia Bosworth, Linus Kuo, Daniel Weisdorf, MD, Stephen J. Forman, MD, Smita Bhatia, MD MPH

Blood (2015) 126 (23): 739.

https://doi.org/10.1182/blood.V126.23.739.739

Published: 2015

Journal Articles

Cardiovascular Disease in Adolescents and Young Adults with Hematologic Malignancies

Chun Chao, PhD, Lanfang Xu, MS, Cooper Robert, MD, Smita Bhatia, MD MPH, Saro Armenian, DO, MPH

Blood (2015) 126 (23): 880.

https://doi.org/10.1182/blood.V126.23.880.880

Published: 2015

Journal Articles

Post Transplant Outcome of a Multicenter Phase II Study of Brentuximab Vedotin As First Line Salvage Therapy in Relapsed/Refractory HL Prior to AHCT

Robert Chen, Joycelynne Palmer, PhD, Peter Martin, MD, Saro Armenian, DO, MPH, Nichun Tsai, Michelle Mott, Firoozeh Sahebi, Ji-Lian Cai, MD PhD, Tanya Siddiqi, MD, Leslie L. Popplewell, MD, John P. Leonard, MD, Auayporn P. Nademanee, MD, Steven T. Rosen, MD, Larry W. Kwak, MD, Stephen J. Forman, MD

Blood (2015) 126 (23): 519.

https://doi.org/10.1182/blood.V126.23.519.519

Published: 2015

Journal Articles

Long-Term Outcomes In Survivors of Childhood Cancer Treated with Hematopoietic Cell Transplantation (HCT) Versus Conventional Therapy: a Report From the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)

Saro Armenian, DO, MPH, Can-Lan Sun, Ph.D., Toana Kawashima, MS, Mukta Arora, MD, Wendy Leisenring, ScD, Charles A. Sklar, MD, K. Scott Baker, MD, MS, Liton Francisco, Jennifer Berano Teh, MD, George Mills, III, F. Lennie Wong, PhD, Joseph Rosenthal, MD, Lisa Diller, MD, Melissa M. Hudson, MD, Kevin C. Oeffinger, MD, Leslie L. Robison, PhD, Smita Bhatia, MD, MPH

Blood (2010) 116 (21): 217.

https://doi.org/10.1182/blood.V116.21.217.217

Published: 2010

Journal Articles

Late Cardiovascular Events in Survivors of Hematopoietic Cell Transplantation (HCT).

Saro Armenian, DO, MPH, Can-Lan Sun, PhD, George Mills, III, BS, Jennifer Berano Teh, MD, Liton Francisco, BS, Lennie Wong, PhD, Stephen J Forman, MD, Smita Bhatia, MD, MPH

Blood (2009) 114 (22): 2252.

https://doi.org/10.1182/blood.V114.22.2252.2252

Published: 2009

Journal Articles

Differential Morbidity by Ethnicity in Long-Term Survivors of Hematopoietic Cell Transplantation (HCT): A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

Saro Armenian, DO, MPh, Can-Lan Sun, Liton Francisco, B.S., K. Scott Baker, MD, MS, Stephen J. Forman, Smita Bhatia, MD, MPH

Blood (2008) 112 (11): 454.

https://doi.org/10.1182/blood.V112.11.454.454

Published: 2008

NARROW

Impact of Self-Reported Pre-Transplant Quality of Life (QOL) on Long-Term Survival after Allogeneic or Autologous Hematopoietic Cell Transplantation (HCT)

Incidence and Predictors of Late-Occurring Central Nervous System Complications in Allogeneic Hematopoietic Cell Transplant Survivors

Progressive Decline in Late Mortality after Hematopoietic Cell Transplantation (HCT) over 40 Years - a Report from BMTSS

Long-Term Morbidity and Mortality Experienced By Chronic Myeloid Leukemia (CML) Patients after Allogeneic Hematopoietic Cell Transplantation (HCT) - a Report from BMTSS-2

Long-Term Follow up of Patients with HIV-Associated Non-Hodgkin Lymphoma (NHL) after Autologous Stem Cell Transplantation (ASCT)

Physiologic Frailty Among Hematopoietic Cell Transplantation (HCT) Survivors Suggests Accelerated Aging and Is a Predictor for Premature Mortality: A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

Cardiovascular Disease in Adolescents and Young Adults with Hematologic Malignancies

Post Transplant Outcome of a Multicenter Phase II Study of Brentuximab Vedotin As First Line Salvage Therapy in Relapsed/Refractory HL Prior to AHCT

Long-Term Outcomes In Survivors of Childhood Cancer Treated with Hematopoietic Cell Transplantation (HCT) Versus Conventional Therapy: a Report From the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)

Late Cardiovascular Events in Survivors of Hematopoietic Cell Transplantation (HCT).

Differential Morbidity by Ethnicity in Long-Term Survivors of Hematopoietic Cell Transplantation (HCT): A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only